Advertisement
Research ArticleArticle

Reduced Expression of DNA Topoisomerase I in SF295 Human Glioblastoma Cells Selected for Resistance to Homocamptothecin and Diflomotecan

Zhiyong Liao, Robert W. Robey, Josée Guirouilh-Barbat, Kenneth K. W. To, Orsolya Polgar, Susan E. Bates and Yves Pommier
Molecular Pharmacology February 2008, 73 (2) 490-497; DOI: https://doi.org/10.1124/mol.107.041178
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Reduced Expression of DNA Topoisomerase I in SF295 Human Glioblastoma Cells Selected for Resistance to Homocamptothecin and Diflomotecan

Zhiyong Liao, Robert W. Robey, Josée Guirouilh-Barbat, Kenneth K. W. To, Orsolya Polgar, Susan E. Bates and Yves Pommier
Molecular Pharmacology February 1, 2008, 73 (2) 490-497; DOI: https://doi.org/10.1124/mol.107.041178
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement